Associations between memory loss and trauma in US asylum seekers: A retrospective review of medico-legal affidavits.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 12 06 2020
accepted: 31 01 2021
entrez: 23 3 2021
pubmed: 24 3 2021
medline: 26 8 2021
Statut: epublish

Résumé

The U.S. immigration system mandates that persons seeking asylum prove their persecution claim is credible and their fear of returning home is well-founded. However, this population represents a highly trauma-exposed group, with neuropsychiatric symptoms consequent to prior torture or maltreatment that may interfere with cognitive function and their ability to recall their trauma. These memory lapses may be incorrectly perceived by asylum adjudicators as indicators of dishonesty and jeopardize the person's credibility and asylum claim. Our retrospective mixed methods study seeks to present associations between trauma and memory loss in a sample of persons seeking asylum to the U.S. and describe how memory impairments manifest in this trauma-exposed population. We randomly selected 200 medico-legal affidavits from 1346 affidavits collected in the past 30 years, as part of the Physicians for Human Rights Asylum Network connecting clinicians with legal providers for medical and/or psychiatric affidavits of U.S. asylum seekers and persons seeking other forms of humanitarian relief (hereafter, "asylum seekers"). Data was extracted from these affidavits using a coding manual informed by the Istanbul Protocol, the global standard for torture documentation. Seven affidavits were excluded due to missing age. We used multiple logistic regression to assess the association of memory loss with neuropsychiatric diagnoses: head trauma, post-traumatic stress disorder (PTSD), and depression. We supplemented these findings with a qualitative content analysis of the affidavits documenting memory loss. Memory loss presented among the asylum seekers' affidavits in several ways: memory gaps of the traumatic event; challenges with presenting a clear chronology of the trauma, avoidance of traumatic memories, and persistent short-term memory loss interfering with daily activity. A majority of the sample received a neuropsychiatric diagnosis: 69% (n = 132) of asylum-seekers received a diagnosis of PTSD and 55% (n = 106) of depression. Head trauma was reported among 30% (n = 58) of affidavits. Further, 68% (n = 131) reported being subject to physical violence and 20% (n = 39) were documented as being at risk of suicide. Memory loss was documented among 21% (n = 40) asylum-seekers. In adjusted models, both PTSD and depression, but not head trauma, were associated with memory loss (p<0.05). Stakeholders in the asylum process, spanning the medical, legal and immigration enforcement sectors, must be aware of the interplay of trauma and memory loss and how they might impact immigration proceedings for this vulnerable population.

Sections du résumé

BACKGROUND
The U.S. immigration system mandates that persons seeking asylum prove their persecution claim is credible and their fear of returning home is well-founded. However, this population represents a highly trauma-exposed group, with neuropsychiatric symptoms consequent to prior torture or maltreatment that may interfere with cognitive function and their ability to recall their trauma. These memory lapses may be incorrectly perceived by asylum adjudicators as indicators of dishonesty and jeopardize the person's credibility and asylum claim. Our retrospective mixed methods study seeks to present associations between trauma and memory loss in a sample of persons seeking asylum to the U.S. and describe how memory impairments manifest in this trauma-exposed population.
METHODS
We randomly selected 200 medico-legal affidavits from 1346 affidavits collected in the past 30 years, as part of the Physicians for Human Rights Asylum Network connecting clinicians with legal providers for medical and/or psychiatric affidavits of U.S. asylum seekers and persons seeking other forms of humanitarian relief (hereafter, "asylum seekers"). Data was extracted from these affidavits using a coding manual informed by the Istanbul Protocol, the global standard for torture documentation. Seven affidavits were excluded due to missing age. We used multiple logistic regression to assess the association of memory loss with neuropsychiatric diagnoses: head trauma, post-traumatic stress disorder (PTSD), and depression. We supplemented these findings with a qualitative content analysis of the affidavits documenting memory loss. Memory loss presented among the asylum seekers' affidavits in several ways: memory gaps of the traumatic event; challenges with presenting a clear chronology of the trauma, avoidance of traumatic memories, and persistent short-term memory loss interfering with daily activity.
RESULTS
A majority of the sample received a neuropsychiatric diagnosis: 69% (n = 132) of asylum-seekers received a diagnosis of PTSD and 55% (n = 106) of depression. Head trauma was reported among 30% (n = 58) of affidavits. Further, 68% (n = 131) reported being subject to physical violence and 20% (n = 39) were documented as being at risk of suicide. Memory loss was documented among 21% (n = 40) asylum-seekers. In adjusted models, both PTSD and depression, but not head trauma, were associated with memory loss (p<0.05).
CONCLUSION
Stakeholders in the asylum process, spanning the medical, legal and immigration enforcement sectors, must be aware of the interplay of trauma and memory loss and how they might impact immigration proceedings for this vulnerable population.

Identifiants

pubmed: 33755695
doi: 10.1371/journal.pone.0247033
pii: PONE-D-20-16257
pmc: PMC7987192
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0247033

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Psychiatr Clin North Am. 2014 Mar;37(1):1-11
pubmed: 24529420
Mayo Clin Proc. 2007 Sep;82(9):1083-90
pubmed: 17803876
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Nat Rev Drug Discov. 2012 Feb 01;11(2):141-68
pubmed: 22293568
Med Leg J. 2001;69(Pt 1):25-34
pubmed: 11388067
Curr Opin Psychiatry. 2009 Jan;22(1):19-24
pubmed: 19122530
Am J Public Health. 2013 Mar;103(3):e30-42
pubmed: 23327250
Isr Med Assoc J. 2014 Mar;16(3):137-41
pubmed: 24761699
Behav Cogn Psychother. 2017 Mar;45(2):97-109
pubmed: 28229806
Lancet. 2005 Apr 9-15;365(9467):1309-14
pubmed: 15823380
BMJ. 2002 Feb 9;324(7333):324-7
pubmed: 11834558
Health Psychol. 2001 Jul;20(4):243-55
pubmed: 11515736
Memory. 2018 Jan;26(1):106-116
pubmed: 28566056
Torture. 2015;25(1):51-61
pubmed: 26021347
Can J Psychiatry. 2005 Nov;50(13):817-22
pubmed: 16483114
BMC Public Health. 2009 Jun 30;9:214
pubmed: 19566954
Health Equity. 2019 Aug 23;3(1):431-435
pubmed: 31448353
J Behav Ther Exp Psychiatry. 2014 Sep;45(3):375-80
pubmed: 24799151
PLoS One. 2017 Aug 23;12(8):e0182276
pubmed: 28832590
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Sci Rep. 2018 Sep 3;8(1):13132
pubmed: 30177846
PLoS Med. 2020 Sep 21;17(9):e1003337
pubmed: 32956381
Neurology. 2020 Nov 10;95(19):e2605-e2609
pubmed: 33004606

Auteurs

Altaf Saadi (A)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Kathryn Hampton (K)

Physicians for Human Rights, New York, New York, United States of America.

Maria Vassimon de Assis (MV)

Master of Development Practice Program, University of California at Berkeley, Berkeley, California, United States of America.

Ranit Mishori (R)

Department of Family Medicine, Georgetown University School of Medicine, Washington, DC, United States of America.

Hajar Habbach (H)

Physicians for Human Rights, New York, New York, United States of America.

Rohini J Haar (RJ)

Division of Epidemiology and Biostatistics, School of Public Health, University of California at Berkeley, Berkeley, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH